Logo

American Heart Association

  2
  0


Final ID:

Discussant: nex-z, also known as NTLA-2001

  • Griffin, Jan  ( MUSC , Charleston , South Carolina , United States )
  • Davis, Margot  ( UNIVERSITY OF BRITISH COLUMBIA , Vancouver , British Columbia , Canada )
  • Cuddy, Sarah  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Author Disclosures:
    Jan Griffin: No Answer | Margot Davis: DO have relevant financial relationships ; Speaker:Pfizer:Active (exists now) ; Consultant:Alnylam:Past (completed) ; Advisor:Ionis:Past (completed) ; Consultant:Novo Nordisk:Past (completed) ; Researcher:AstraZeneca:Active (exists now) | Sarah Cuddy: DO have relevant financial relationships ; Advisor:Bridgebio:Active (exists now) ; Advisor:Ionis:Active (exists now) ; Advisor:Astra Zeneca:Active (exists now) ; Speaker:Pfizer:Active (exists now) ; Speaker:Novo Nordisk:Active (exists now)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Celebrating a Century of Cardiovascular Science: From Prevention to Treatment, to Cure

Saturday, 11/16/2024 , 08:30AM - 09:45AM

Late-Breaking Science

More abstracts from these authors:
Novel Therapies in the Management of Cardiac Amyloidosis and Access to Care

Falk Rodney, Kittleson Michelle, Cuddy Sarah

Clonal hematopoiesis portends worse mortality among individuals with ATTR cardiac amyloidosis

Small Aeron, Vijayakumar Shilpa, Cuddy Sarah, Libby Peter, Natarajan Pradeep, Gaggin Hanna, Dorbala Sharmila, Honigberg Michael

You have to be authorized to contact abstract author. Please, Login
Not Available